NA

Neeru Arora

Director Director DIN 01733313
DIN 01733313 First appointment Sep 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2005
Shareholding value •••• Premium profile

About Neeru Arora

Data last updated:

Neeru Arora was a Director at Arosol Chemicals Private Limited (2005–2018) and Director at Argano Organic Limited (2010–2018). The companies operate in Pharma and Agriculture.

DIN 01733313
Primary Designation Director
Industry Pharma
First Appointment 26 Sep 2005

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arosol Chemicals Private Limited U24112UP1987PTC008667
Director26 Sep 20051987₹4.89 Cr (FY 2025)Active
Argano Organic Limited U24233UP2010PLC039121
Director01 Jan 20102010₹25.84 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arosol Chemicals Private Limited
Argano Organic Limited
Premium access

Shareholding and investment profile for Neeru Arora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeru Arora

Neeru Arora was first appointed on 26 Sep 2005 as Director at Arosol Chemicals Private Limited. The most recent appointment on record is 01 Jan 2010 at Argano Organic Limited.

Neeru Arora held 2 earlier board appointments: Arosol Chemicals Private Limited (Director, 26 Sep 2005 to 25 Jul 2018); Argano Organic Limited (Director, 01 Jan 2010 to 25 Jul 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available